Tonix Pharma (TNXP) Says Interim Analysis Shows TNX-102 SL Unlikely to Demonstrate Statistically Significant Improvement, Enrollment Stopped
Go back to Tonix Pharma (TNXP) Says Interim Analysis Shows TNX-102 SL Unlikely to Demonstrate Statistically Significant Improvement, Enrollment Stopped| TONIX PHARM HLDG (NASDAQ: TNXP) | Delayed: 12.22 +0.02 (0.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.20 | 52 Week High | $7.95 | |||
| Open | $11.79 | 52 Week Low | $0.40 | |||
| Day High | $12.58 | P/E | N/A | |||
| Day Low | $11.78 | EPS | $-5.33 | |||
| Volume | 230,664 | |||||

